Segal, Jeremy P.
University of Chicago
3 papers on CoChatORCID 0000-0002-0958-3295
Most cited papers
- Verified
Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma
Trujillo, J. A., Luke, J. J., Zha, Y., Segal, J. P., Ritterhouse, L. L., Spranger, S., Matijevich, K., & Gajewski, T. F. (2019) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 159
- Verified
Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL
Kadri, S., Lee, J., Fitzpatrick, C., Galanina, N., Sukhanova, M., Venkataraman, G., Sharma, S., Long, B., Petras, K., Theissen, M., et al. (2017) · Blood Advances
Chronic Lymphocytic Leukemia ResearchAcute Myeloid Leukemia Research
Cited by 133
- Verified
Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL
Sharma, S., Galanina, N., Guo, A., Lee, J., Kadri, S., Van Slambrouck, C., Long, B., Wang, W., Ming, M., Furtado, L. V., et al. (2016) · Oncotarget
Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment
Cited by 90
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free